Platform
Features
0 followers
Urovant Sciences, innovations in urology. Our lead therapeutic candidate is vibegron (RVT-901), an investigational oral β3-adrenergic agonist
Industries
Headquarters
Employees
Links
James Robinson
33 members
10 members
5 members
8 members
Tessera Therapeutics
2 followers
Vaxcyte
Day One Biopharmaceuticals
1 follower
QurAlis
Edgewise Therapeutics
Abcuro
Generate Biomedicines
3 followers
Qureator
OncoPrecision
11 followers
eGenesis
Thermo Fisher Scientific
173 followers
Explore companies